Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

Total Assets Summary of Medtecs International Corporation Limited

Medtecs International Corporation Limited's latest annual total assets in 2023 was 166.76 Million USD , down -8.39% from previous year.
Medtecs International Corporation Limited's latest quarterly total assets in 2024 Q2 was 161.13 Million USD , down -3.38% from previous quarter.
Medtecs International Corporation Limited reported annual total assets of 182.04 Million USD in 2022, down -15.55% from previous year.
Medtecs International Corporation Limited reported annual total assets of 215.57 Million USD in 2021, down -12.26% from previous year.
Medtecs International Corporation Limited reported quarterly total assets of 166.76 Million USD for 2023 Q4, down -8.23% from previous quarter.
Medtecs International Corporation Limited reported quarterly total assets of 166.76 Million USD for 2023 FY, down -8.39% from previous quarter.

Annual Total Assets Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Total Assets of Medtecs International Corporation Limited (2023 - 2009)

Year	Total Assets	Total Assets Growth
2023	166.76 Million USD	-8.39%
2022	182.04 Million USD	-15.55%
2021	215.57 Million USD	-12.26%
2020	245.68 Million USD	110.7%
2019	116.6 Million USD	3.29%
2018	112.89 Million USD	3.06%
2017	109.53 Million USD	3.69%
2016	105.63 Million USD	-3.35%
2015	109.29 Million USD	4.38%
2014	104.7 Million USD	-6.02%
2013	111.41 Million USD	-1.63%
2012	113.26 Million USD	3.48%
2011	109.46 Million USD	-3.31%
2010	113.21 Million USD	10.69%
2009	102.27 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	161.13 Million USD	-3.38%
2023 Q4	166.76 Million USD	-8.23%
2023 FY	166.76 Million USD	-8.39%
2023 Q2	181.73 Million USD	-0.18%
2022 FY	182.04 Million USD	-15.55%
2022 Q4	182.04 Million USD	-19.98%
2022 Q2	227.5 Million USD	5.54%
2021 Q4	215.57 Million USD	2.76%
2021 FY	215.57 Million USD	-12.26%
2021 Q2	209.77 Million USD	-14.62%
2020 FY	245.68 Million USD	110.7%
2020 Q4	245.68 Million USD	46.21%
2020 Q2	168.04 Million USD	44.11%
2019 FY	116.6 Million USD	3.29%
2019 Q4	116.6 Million USD	3.23%
2019 Q2	112.95 Million USD	0.06%
2018 Q2	113.56 Million USD	3.67%
2018 Q4	112.89 Million USD	-0.59%
2018 FY	112.89 Million USD	3.06%
2017 Q2	110.42 Million USD	4.53%
2017 Q4	109.53 Million USD	-0.8%
2017 FY	109.53 Million USD	3.69%
2016 Q4	105.63 Million USD	-3.11%
2016 FY	105.63 Million USD	-3.35%
2016 Q2	109.03 Million USD	-0.24%
2015 Q2	109.21 Million USD	4.3%
2015 FY	109.29 Million USD	4.38%
2015 Q4	109.29 Million USD	0.08%
2014 FY	104.7 Million USD	-6.02%
2014 Q4	104.7 Million USD	-1.76%
2014 Q2	106.59 Million USD	-4.33%
2013 FY	111.41 Million USD	-1.63%
2013 Q4	111.41 Million USD	-1.87%
2013 Q2	113.53 Million USD	0.24%
2012 FY	113.26 Million USD	3.48%
2012 Q4	113.26 Million USD	3.66%
2012 Q2	109.26 Million USD	-0.18%
2011 FY	109.46 Million USD	-3.31%
2011 Q2	116.33 Million USD	2.76%
2011 Q4	109.46 Million USD	-5.91%
2010 Q2	106.79 Million USD	4.42%
2010 FY	113.21 Million USD	10.69%
2010 Q4	113.21 Million USD	6.01%
2009 Q2	106.11 Million USD	0.0%
2009 Q4	102.27 Million USD	-3.62%
2009 FY	102.27 Million USD	0.0%

Peer Total Assets Comparison of Medtecs International Corporation Limited

Name	Total Assets	Total Assets Difference
Nang Kuang Pharmaceutical Co., Ltd.	3.85 Billion TWD	95.675%
Maxigen Biotech Inc.	1.49 Billion TWD	88.83%
SciVision Biotech Inc.	2.16 Billion TWD	92.28%
Bionime Corporation	5.3 Billion TWD	96.854%
Pegavision Corporation	13.85 Billion TWD	98.797%
Visco Vision Inc.	4.72 Billion TWD	96.47%